daniel catenacci, md, discusses margetuximab in the treatment of esophageal and gastric cancer
Published 4 years ago • 70 plays • Length 3:11Download video MP4
Download video MP3
Similar videos
-
1:01
daniel catenacci, md, on the role of margetuximab to improve treatment outcomes of gi cancers
-
2:10
daniel catenacci, md, shares opinion on the role of checkpoint inhibitors for gi malignancies
-
2:00
dr. catenacci on the challenges of developing novel therapies in gastroesophageal cancer
-
2:59
clinical implications of her2 in gi cancers
-
1:43
gastroesophageal carcinoma with her2 gene amplification
-
2:43
daniel catenacci, md, elaborates on the outcomes of the javelin 100 study presented at asco gi 2020
-
4:06
bemarituzumab in solid tumors
-
1:46
determining the optimal timing for immunotherapy in patients with gej cancers
-
11:17
whipple procedure survival rate/pancreatic cancer surgery
-
9:32
medullary thyroid cancer treatment overview.
-
51:38
medical update: her2-positive and triple-positive metastatic breast cancer
-
3:52
her2-positive gastric cancer
-
6:38
potential new options for patients with her2 gastric cancer
-
0:51
dr. deirdre cohen on when to treat gastric cancer patients with immunotherapies
-
0:26
nevena damjanov, md, elaborates on the role of tkis in managing 2nd line hcc patients
-
1:24
treatment de-escalation and escalation strategies in her2-positive breast cancer
-
1:45
dr. pegram on a phase ii trial of mgah22 in breast cancer
-
0:53
how do you decide which therapy to use to treat pancreatic cancer? (douglas evans, md)
-
1:56
dr. chavez mac gregor on chemotherapy in node-positive hr /her2- breast cancer
-
2:14
innovative approaches to the treatment of head and neck cancer
-
26:18
the impact of cancer treatment on the heart
-
2:31
efficacy of second-line chemotherapy in advanced cca with fgfr2 fusions